Aidoc provides clinical AI and medical imaging tools for healthcare providers. Its imaging AI helps radiologists prioritize findings and coordinate care.

Is Aidoc publicly traded?

No. Aidoc is a private company, so its shares are not listed on a public stock exchange and it has no ticker symbol. It is preparing to go public, which is the strongest public signal available so far.

What is Aidoc's stock price?

Exenro's fair-price estimate for Aidoc is $35.53 per share as of Sep 2026. It is an indicative research estimate rather than a quote, an offer, or a price anyone is able to transact at, and it is revised as new information arrives.

Aidoc is preparing to go public, but Exenro has not verified a public filing or a confirmed offering date. Exenro re-checks IPO signals continuously and updates this page when the status changes.

How can I buy Aidoc stock before the IPO?

Shares in private companies such as Aidoc generally change hands on the secondary market, where access is normally restricted to accredited investors and the company can approve or block a transfer. Exenro publishes research and estimates on private companies; it is not a broker-dealer and does not sell shares.

Aidoc

HealthcareNew York, USFounded 2016

Price per share

$35.53

Aidoc's indicated price is model-derived from secondary-market and reference data and may differ from actual transaction prices. Disclosures

About Aidoc

Secondary Market

Price per share

$35.53

Aidoc key metrics

Aidoc business model

Aidoc competitors and similar companies

Aidoc — frequently asked questions

What is Aidoc?: Aidoc provides clinical AI and medical imaging tools for healthcare providers. Its imaging AI helps radiologists prioritize findings and coordinate care.
Is Aidoc publicly traded?: No. Aidoc is a private company, so its shares are not listed on a public stock exchange and it has no ticker symbol. It is preparing to go public, which is the strongest public signal available so far.
What is Aidoc's stock price?: Exenro's fair-price estimate for Aidoc is $35.53 per share as of Sep 2026. It is an indicative research estimate rather than a quote, an offer, or a price anyone is able to transact at, and it is revised as new information arrives.
When will Aidoc IPO?: Aidoc is preparing to go public, but Exenro has not verified a public filing or a confirmed offering date. Exenro re-checks IPO signals continuously and updates this page when the status changes.
How can I buy Aidoc stock before the IPO?: Shares in private companies such as Aidoc generally change hands on the secondary market, where access is normally restricted to accredited investors and the company can approve or block a transfer. Exenro publishes research and estimates on private companies; it is not a broker-dealer and does not sell shares.

Companies Aidoc

Aidoc

Healthcare & Life SciencesNew York, US

Aidoc's indicated price is model-derived from secondary-market and reference data and may differ from actual transaction prices. Disclosures